Literature DB >> 24239096

Effect of platelet-rich plasma on fibrocartilage, cartilage, and bone repair in temporomandibular joint.

Nükhet Kütük1, Burcu Baş2, Emrah Soylu3, Zeynep Burçin Gönen3, Canay Yilmaz3, Esra Balcioğlu4, Saim Özdamar5, Alper Alkan6.   

Abstract

PURPOSE: The purpose of the present study was to explore the potential use of platelet-rich-plasma (PRP) in the treatment of temporomandibular joint osteoarthritis (TMJ-OA).
MATERIALS AND METHODS: Surgical defects were created bilaterally on the condylar fibrocartilage, hyaline cartilage, and bone to induce an osteoarthritic TMJ in rabbits. PRP was applied to the right joints of the rabbits (PRP group), and the left joints received physiologic saline (control group). After 4 weeks, the rabbits were sacrificed for histologic and scanning electron microscopy (SEM) examinations. The data were analyzed statistically.
RESULTS: The new bone regeneration was significantly greater in the PRP group (P < .011). Although the regeneration of the fibrocartilage and hyaline cartilage was greater in the PRP group, no statistically significant difference was found between the 2 groups. SEM showed better ultrastructural architecture of the collagen fibrils in the PRP group.
CONCLUSIONS: PRP might enhance the regeneration of bone in TMJ-OA.
Copyright © 2014 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24239096     DOI: 10.1016/j.joms.2013.09.011

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  9 in total

1.  Research progress on tissue engineering in repairing tempomandibular joint.

Authors:  Chenyu Wang; Yingnan Wang; Cunyi Wang; Jiejun Shi; Huiming Wang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-04-25

2.  Necessity of standardized protocol for platelet-rich plasma therapy in temporomandibular joint osteoarthritis.

Authors:  Su-Gwan Kim
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2016-04-27

Review 3.  Application of platelet-rich plasma with stem cells in bone and periodontal tissue engineering.

Authors:  Gabriela Fernandes; Shuying Yang
Journal:  Bone Res       Date:  2016-12-13       Impact factor: 13.567

4.  Histological and Immunohistochemical Analyses of Repair of the Disc in the Rabbit Temporomandibular Joint Using a Collagen Template.

Authors:  Kuo-Hwa Wang; Wing P Chan; Li-Hsuan Chiu; Yu-Hui Tsai; Chia-Lang Fang; Charn-Bing Yang; Kuan-Chou Chen; Hung-Li Tsai; Wen-Fu Lai
Journal:  Materials (Basel)       Date:  2017-08-09       Impact factor: 3.623

5.  The combined use of kartogenin and platelet-rich plasma promotes fibrocartilage formation in the wounded rat Achilles tendon entheses.

Authors:  J Zhang; T Yuan; N Zheng; Y Zhou; M V Hogan; J H-C Wang
Journal:  Bone Joint Res       Date:  2017-04       Impact factor: 5.853

6.  Clinical efficacy of a centric relation occlusal splint and intra-articular liquid phase concentrated growth factor injection for the treatment of temporomandibular disorders.

Authors:  Jung-Wu Yang; Yi-Chia Huang; Shang-Liang Wu; Shun-Yao Ko; Chiang-Chin Tsai
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

Review 7.  Advances in Tissue Engineering of the Temporomandibular Joint Disc: An Overview of Current Status and Future Directions.

Authors:  Ashutosh Kumar Singh; Nikita Khanal; Rajib Chaulagain
Journal:  Int J Dent       Date:  2022-07-22

8.  Mesenchymal stem cells-derived microvesicles versus platelet-rich plasma in the treatment of monoiodoacetate-induced temporomandibular joint osteoarthritis in Albino rats.

Authors:  Nermeen AbuBakr; Amira E Fares; Abeer Mostafa; Dina B E Farag
Journal:  Heliyon       Date:  2022-10-01

Review 9.  Platelet-rich plasma in bone regeneration: engineering the delivery for improved clinical efficacy.

Authors:  Isaac A Rodriguez; Emily A Growney Kalaf; Gary L Bowlin; Scott A Sell
Journal:  Biomed Res Int       Date:  2014-06-23       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.